Eversept Partners, LP Protara Therapeutics, Inc. Transaction History

Eversept Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$13.75 - $23.86 $499,262 - $866,356	-36,310 Closed	0 $0
Q4 2020 Nov 08, 2023	BUY	$16.97 - $25.34 $616,180 - $920,095	36,310 New	36,310 $879,000
Q3 2020 Nov 08, 2023	SELL	$16.76 - $31.89 $167,600 - $318,900	-10,000 Reduced 21.59%	36,310 $611,000
Q3 2020 Nov 13, 2020	SELL	$16.76 - $31.89 $167,600 - $318,900	-10,000 Reduced 21.59%	36,310 $611,000
Q2 2020 Nov 08, 2023	BUY	$22.0 - $60.7 $1.02 Million - $2.81 Million	46,310 New	46,310 $1.36 Million
Q2 2020 Aug 13, 2020	BUY	$22.0 - $60.7 $1.02 Million - $2.81 Million	46,310 New	46,310 $1.36 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $53M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.